• Call: +44-2038074155  |  Mail: Sales@brandessenceresearch.com  | | | | |

Tubeless Insulin Pump Market 2021 By component (Pod/patch, Remote, Others), By Distribution Channel (Hospitals, Pharmacies, E-commerce, Others) Forecast to 2027

  • Report ID: BMRC 1068 | Number of pages: 200 | Published Date: Apr 2020

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Tubeless Insulin Pump Market 2021 By component (Pod/patch, Remote, Others), By Distribution Channel (Hospitals, Pharmacies, E-commerce, Others) Forecast to 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

"Global tubeless insulin pump market is valued at USD 533.19 Million in 2018 and expected to reach USD 2389.92 Million by 2025 with the CAGR of 23.90% over the forecast period."

Escalating prevalence of diabetes and obesity, growing geriatric population and technological advancement in tubeless insulin delivery are some factors driving the growth of market.

Scope of Tubless Insulin Pump Market Report:

Insulin Pump which is also referred to as continous subcutaneous insulin infusion is rapidly gaining popularity across the medical device industry. This medical device makes use of near-physiologic basal-bolus procedure for delivery of insulin and it is flexible as well as lifestyle-friendly method. Insulin pump withoud tubing (patch pump), Tubeless patch pumps contain the insulin reservior and the infusion cannula and adhere directly to the skin. A handeled device is used to program insulin delivery and insert the infusion cannula. This tubeless patch pump (pod) operated by a handeled device called the “PDM” that is wirelessly connected to bluetooth. Moreover, tubeless insulin pump are tiny, unobtrusive and lightweight in nature and are also referred as insulin patch pumps. These products are discrete, cost-effective, easily adhere to human skin and easy to use.  Currently, these pumps make use of nitinol wire, spring, step motor, piezoelectric crystal, manual pumping chamber, and bladder for insulin delivery. These tubeless insulin pumps are available in myriad sizes and technologies. These products can be worn and effectively handled under clothing.

Global tubeless insulin pump market segmented on the basis of component, distribution channel and by regional. On the basis of component, the market is segmented in to pod/patch, remote and others. On the basis of distribution channel, the market is semented in to hospitals, pharmacies, e-commerce and others.

The regions covered in this tubeless insulin pump market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Tubeless Insulin Pump Manufacturers:

  • Insulet Corporation
  •  Johnson & Johnson
  • Medtrum Technologies
  • Cellnova
  • Roche Holdings
  • Spring Health Solutions
  • Debiotech
  • CeQur
  • Valeritas Holding
  • Abbott Diabetes Care
  • Medtronic Plc.
  • Tandem Diabetes Care
  • Insulet Corporation
  • Animas Corporation
  • Others

Tubeless Insulin Pump

Global Tubeless Insulin Pump Market Dynamics

With mounting cases of diabetes, especially among geriatric patients, the tubeless insulin pump market is estimated to witness significant growth over forecast period. According to American Diabetes Association,  In 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Almost 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Additionally, Development of novel insulin delivery devices will further boost the market growth. Lightweight and disposable pod such as Omnipod, by Ypsomed, endlessly delivers insulin for upto three days and is connected with a remote to conclude insulin delivery intervals. Correspondingly, in March 2019, the United States FDA gave fast-track title to EoPancreas, an Automated Insulin Delivery (AID) system, by EoFlow. However, partial reimbursement for tubeless insulin pump and drastically rising cost of insulin delivery systems may hinder the market growth in forthcoming years. Moreover, new products to the product line and constant addition of new features to the existing products will boost the market opportunity over the coming years.

Global Tubeless Insulin Pump Market Regional Analysis

North America dominate tubeless insulin pump market, due to factors such as rising population base suffering from diabetes as well as increasing spending on insulin uptake per person will highly impact the demand for tubeless insulin pump market in this region. According to Canadian Community Health Survey, in 2017, 7.3% of Canadians aged 12 and older (roughly 2.3 million people) reported being diagnosed with diabetes. In addition, new product launch and continuous upgradation in technology will expand market growth in the forecast period.

Asia-Pacific is expected to be the highest growing region due to increasing government initiatives to enhance awareness about effective diabetes management. For example, the Australian Ministry of Health funded 100 million for extending promotional action of insulin, in year 2018. The project provides fully subsidized insulin monitor device to patients age below 21 years of age that are affected with diabetes. Hence, increasing government initiatives and diabetes care awareness among patients will rise the demand for tubeless insulin pump market in this region.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2020: USD 533.19 Million 
Base year considered 2020
Forecast Period CAGR %:

23.90 %

Market Size Expected in 2027: USD 2389.92 Million 
Tables, Charts & Figures: 175
Pages 200
Key Players/Companies Insulet Corporation, Johnson & Johnson,Medtrum Technologies,Cellnova,Roche Holdings,Spring Health Solutions,Debiotech,CeQur,Valeritas Holding,Abbott Diabetes Care,Medtronic Plc.,Tandem Diabetes Care,Insulet Corporation,Animas Corporation,Others
Segments Covered By Distribution Channel, By Component
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Global Tubeless Insulin Pump Market Reports–

Global Tubeless Insulin Pump Market report covers in depth historical and forecast analysis.

Global Tubeless Insulin Pump Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Tubeless Insulin Pump Market report helps to identify opportunities in market place.

Global Tubeless Insulin Pump Market report covers extensive analysis of emerging trends and competitive landscape.

Global Tubeless Insulin Pump Market Segmentation:

By component: Pod/patch, Remote, Others

By Distribution Channel: Hospitals, Pharmacies, E-commerce, Others

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa


Frequently Asked Questions (FAQ) :
Escalating prevalence of diabetes and obesity, growing geriatric population and technological advancement in tubeless insulin delivery are some factors driving the growth of market.
"Global tubeless insulin pump market is valued at USD 533.19 Million in 2018 and expected to reach USD 2389.92 Million by 2025 with the CAGR of 23.90% over the forecast period."
North America dominate tubeless insulin pump market, due to factors such as rising population base suffering from diabetes as well as increasing spending on insulin uptake per person will highly impact the demand for tubeless insulin pump market in this region
Insulet Corporation, Johnson & Johnson,Medtrum Technologies,Cellnova,Roche Holdings,Spring Health Solutions,Debiotech,CeQur,Valeritas Holding,Abbott Diabetes Care,Medtronic Plc.,Tandem Diabetes Care,Insulet Corporation,Animas Corporation,Others



Interested in this report?

Tubeless Insulin Pump Market| REGIONAL ANALYSIS AND FORECAST 2027 and Analysis 2019-2025

report cover

Tubeless Insulin Pump Market 2021 By component (Pod/patch, Remote, Others), By Distribution Channel (Hospitals, Pharmacies, E-commerce, Others) Forecast to 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.

    Pricing



+44-1173181773
vishal@brandessenceresearch.com


Looking for Regional Reports?